Suppr超能文献

诱导针对西尼罗河病毒感染的保护性抗体反应需要补体激活。

Complement activation is required for induction of a protective antibody response against West Nile virus infection.

作者信息

Mehlhop Erin, Whitby Kevin, Oliphant Theodore, Marri Anantha, Engle Michael, Diamond Michael S

机构信息

Department of Medicine, Molecular Microbiology, and Pathology & Immunology, Washington University School of Medicine, 660 South Euclid Ave., Box 8051, St. Louis, MO 63110, USA.

出版信息

J Virol. 2005 Jun;79(12):7466-77. doi: 10.1128/JVI.79.12.7466-7477.2005.

Abstract

Infection with West Nile virus (WNV) causes a severe infection of the central nervous system (CNS) with higher levels of morbidity and mortality in the elderly and the immunocompromised. Experiments with mice have begun to define how the innate and adaptive immune responses function to limit infection. Here, we demonstrate that the complement system, a major component of innate immunity, controls WNV infection in vitro primarily in an antibody-dependent manner by neutralizing virus particles in solution and lysing WNV-infected cells. More decisively, mice that genetically lack the third component of complement or complement receptor 1 (CR1) and CR2 developed increased CNS virus burdens and were vulnerable to lethal infection at a low dose of WNV. Both C3-deficient and CR1- and CR2-deficient mice also had significant deficits in their humoral responses after infection with markedly reduced levels of specific anti-WNV immunoglobulin M (IgM) and IgG. Overall, these results suggest that complement controls WNV infection, in part through its ability to induce a protective antibody response.

摘要

西尼罗河病毒(WNV)感染会导致严重的中枢神经系统(CNS)感染,在老年人和免疫功能低下者中发病率和死亡率更高。对小鼠进行的实验已开始明确先天性免疫反应和适应性免疫反应如何发挥作用来限制感染。在此,我们证明补体系统作为先天性免疫的主要组成部分,主要通过中和溶液中的病毒颗粒以及裂解WNV感染的细胞,以抗体依赖的方式在体外控制WNV感染。更具决定性的是,基因上缺乏补体第三成分或补体受体1(CR1)和CR2的小鼠,其CNS病毒载量增加,并且在低剂量WNV感染时易发生致命感染。C3缺陷小鼠以及CR1和CR2缺陷小鼠在感染后其体液反应也存在显著缺陷,特异性抗WNV免疫球蛋白M(IgM)和IgG水平明显降低。总体而言,这些结果表明补体控制WNV感染,部分是通过其诱导保护性抗体反应的能力实现的。

相似文献

4
Protective immune responses against West Nile virus are primed by distinct complement activation pathways.
J Exp Med. 2006 May 15;203(5):1371-81. doi: 10.1084/jem.20052388. Epub 2006 May 1.
5
Persistence of West Nile virus-specific antibodies in viremic blood donors.
Clin Vaccine Immunol. 2007 Sep;14(9):1228-30. doi: 10.1128/CVI.00233-07. Epub 2007 Jul 25.
6
A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
Vaccine. 2018 Mar 27;36(14):1846-1852. doi: 10.1016/j.vaccine.2018.02.073. Epub 2018 Feb 26.
10
CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system.
J Virol. 2006 Dec;80(24):12060-9. doi: 10.1128/JVI.01650-06. Epub 2006 Oct 11.

引用本文的文献

1
Leukocyte recruitment in flavivirus-induced encephalitis.
Front Immunol. 2025 Aug 22;16:1650903. doi: 10.3389/fimmu.2025.1650903. eCollection 2025.
2
C3 deficiency promotes pulmonary inflammation in AT1R-induced mouse model for systemic sclerosis.
Front Immunol. 2024 Dec 16;15:1491324. doi: 10.3389/fimmu.2024.1491324. eCollection 2024.
3
Complement and T cell activation in transplantation.
Transplant Rev (Orlando). 2025 Jan;39(1):100898. doi: 10.1016/j.trre.2024.100898. Epub 2024 Nov 26.
6
New Insights into the Role of the Complement System in Human Viral Diseases.
Biomolecules. 2022 Jan 28;12(2):226. doi: 10.3390/biom12020226.
10
Arboviruses: How Saliva Impacts the Journey from Vector to Host.
Int J Mol Sci. 2021 Aug 25;22(17):9173. doi: 10.3390/ijms22179173.

本文引用的文献

1
Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus.
Nat Med. 2005 May;11(5):522-30. doi: 10.1038/nm1240. Epub 2005 Apr 24.
2
Structure and intracellular targeting of the SARS-coronavirus Orf7a accessory protein.
Structure. 2005 Jan;13(1):75-85. doi: 10.1016/j.str.2004.10.010.
3
West Nile virus: crossing the blood-brain barrier.
Nat Med. 2004 Dec;10(12):1294-5. doi: 10.1038/nm1204-1294.
4
Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis.
Nat Med. 2004 Dec;10(12):1366-73. doi: 10.1038/nm1140. Epub 2004 Nov 21.
5
The complement system in regulation of adaptive immunity.
Nat Immunol. 2004 Oct;5(10):981-6. doi: 10.1038/ni1113.
6
West Nile virus: where are we now?
Lancet Infect Dis. 2004 Sep;4(9):547-56. doi: 10.1016/S1473-3099(04)01128-4.
8
C4BQ0: a genetic marker of familial HCV-related liver cirrhosis.
Dig Liver Dis. 2004 Jul;36(7):471-7. doi: 10.1016/j.dld.2004.02.007.
9
Role of CD8+ T cells in control of West Nile virus infection.
J Virol. 2004 Aug;78(15):8312-21. doi: 10.1128/JVI.78.15.8312-8321.2004.
10
Immunity to West Nile virus.
Curr Opin Immunol. 2004 Aug;16(4):519-23. doi: 10.1016/j.coi.2004.05.008.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验